About Us
Who we are?
One Cell DiagnosticsTM Inc., a genomics-based Precision Oncology company, based in Silicon Valley, CA and with India operations. We provide comprehensive genomic solutions for better cancer management leveraging cutting-edge Next-Generation Sequencing technology in combination with strong bioinformatics, AI and ML technology for Multi-omics Biomarker.
We are a team of dedicated oncologists, researchers and scientists from top hospitals and universities across the world working on
- Research oriented, quality driven and cost-effective
- Equipped with high-end laboratory equipment and computational tools including the Illumina NextSeq platform
- Clinically and analytically validated for accurate and reliable testing
- Partnerships across diverse educational and healthcare institutions
Our Mission
Our mission is to revolutionize cancer care and by providing high-quality precision therapy options to all needful patients across the world at affordable rates.
What we do?
Our cutting-edge Next-Generation Sequencing technology in combination with strong bioinformatics platforms helps achieve the following:
- Comprehensive cancer genomic testing assay that covers more than 600 genes for both Liquid and Tissue biopsy
- Detection of key biomarkers via comprehensive genomic profiling to identify and predict response to targeted therapies
- Design of individual treatment plans for needful patients globally
- Since currently available NGS based diagnostic tests are either expensive or output low-quality and unreliable data, our tests have been specially designed to be affordable while maintaining throughput, sensitivity and specificity at par with international standards
- Deliver faster, affordable, and deeper coverage of specific biomarkers that can guide precision treatment decisions including Chemotherapy, Targeted Therapy, and Immunotherapy with high precision and reliability
Our Team
Mohan Uttarwar
Team India
Dr.Jayant Khandare
Dr.Gowhar Shafi
Aravindan Vasudevan
Dr.Jayant Khandare
Dr.Gowhar Shafi
Aravindan Vasudevan
G.R.R. Vittala
Team USA
Board of Directors
Mohan Uttarwar
Vijay Uttarwar
Rick Kamble
Dr.Jayant Khandare
Richard Friedberg
Press Release
OneCellDx and Genetics Institute of America Partner to Launch OncoPredikt HRD Assay
- Ideal for HRD Screening Pharma Development
- AI Enabled Algorithm
- Poster Session at ASCO 2022
OneCellDx to Present Data on AI and ML-based HRD and CTC testing at 2022 American Society of Clinical Oncology, Annual Meeting
OneCellDx and Genetics Institute of America Partner to Launch OncoPredikt HRD Assay
- Ideal for HRD Screening Pharma Development
- AI Enabled Algorithm
- Poster Session at ASCO 2022